Ceftriaxone

Treatment for Gonorrhea

Typical Dosage: 500 mg IM single dose

Effectiveness
98%
Safety Score
70%
Clinical Trials
17
Participants
100K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
500 mg IM single dose
Time to Effect
24-48 hours
Treatment Duration
Single IM dose
Evidence Quality
HIGH
Number Needed to Treat (NNT)
1(Treat 1 patients to see 1 additional successful outcome)
Confidence Score
98%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$20
Monitoring:$300
Side Effect Mgmt:$10
Total Annual:$330
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
0.05
Outcome-Based Costs
Cost per Responder
$336.73
Cost per Remission
$336.73
Prescription Access Economics
Annual Societal Loss per Patient
$350
Cost of prescription-only barriers (visits, time, admin, price premium)
Physician Visit Cost
$300/year
Time Cost
$60/year
Travel + wait time
Insurance Admin Cost
$20/year
Prior auth, claims
Rx Price
$20/year
Potential OTC Price
$50/year
Estimated if OTC available
Early Treatment Benefit
+0.05 QALYs
From faster OTC access
Risk Assessment
Misuse Risk
LOW
Missed Diagnosis Risk
MODERATE
Ceftriaxone Outcomes

for Gonorrhea

Efficacy Outcomes
Overall Effectiveness
+98%
Response Rate
+98%
Remission Rate
+98%
Common Side Effects
Injection site pain
+15%
Diarrhea
+7%
Nausea/Vomiting
+2%
Rash
+1%
Headache
+1%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
1 active trial recruiting for Ceftriaxone in Gonorrhea

Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae

NCT05294588RECRUITINGPHASE2
View Study
140 participants
INTERVENTIONAL
Chapel Hill, United States
Started: Apr 18, 2022
Completed Clinical Trials
13 completed trials for Ceftriaxone in Gonorrhea

Cefixime Plus Doxycycline Compared to Ceftriaxone Plus Azithromycin for Treatment of Gonorrhoea

NCT06090565COMPLETEDPHASE4
View Study
161 participants
INTERVENTIONAL
Prague, Czechia +1 more
Started: Apr 1, 2021

Randomized, Open-label Phase 2 Study of Oral AZD0914 in the Treatment of Gonorrhea

NCT02257918COMPLETEDPHASE2
View Study
180 participants
INTERVENTIONAL
Birmingham, United States +4 more
Started: Nov 25, 2014

A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea

NCT04010539COMPLETEDPHASE3
View Study
628 participants
INTERVENTIONAL
Los Angeles, United States +50 more
Started: Oct 21, 2019

Zoliflodacin in Uncomplicated Gonorrhoea

NCT03959527COMPLETEDPHASE3
View Study
1.01K participants
INTERVENTIONAL
Birmingham, United States +16 more
Started: Nov 6, 2019

A Study Evaluating Efficacy and Safety of CRO-SBT in the Treatment of Gonorrhea

NCT04202068COMPLETEDPHASE4
View Study
113 participants
INTERVENTIONAL
Started: Jul 3, 2015

Efficacy and Safety Study of Oral Solithromycin Compared to Intramuscular Ceftriaxone Plus Oral Azithromycin in the Treatment of Patients With Gonorrhea

NCT02210325COMPLETEDPHASE3
View Study
264 participants
INTERVENTIONAL
Baltimore, United States +4 more
Started: Aug 1, 2014

Trial Comparing Ceftriaxone Plus Azithromycin Versus Ceftriaxone for the Treatment of Gonorrhea

NCT05027516COMPLETEDPHASE4
View Study
42 participants
INTERVENTIONAL
Antwerp, Belgium
Started: Jan 17, 2022

Response Rate to Ceftriaxone 1g IM in Gonorrhoea : a French Retrospective Monocentric Study

NCT04902560COMPLETED
View Study
120 participants
OBSERVATIONAL
Montpellier, France
Started: May 1, 2021

New AntiBiotic Treatment Options for Uncomplicated Anogenital GOnorrhoea

NCT03294395COMPLETEDPHASE3
View Study
346 participants
INTERVENTIONAL
Amsterdam, Netherlands
Started: Sep 18, 2017

Experimental Human Infection With Neisseria Gonorrhoeae (LptA Trial)

NCT04870138COMPLETEDPHASE1
View Study
16 participants
INTERVENTIONAL
Chapel Hill, United States
Started: Mar 10, 2013

Experimental Human Infection With Neisseria Gonorrhoeae

NCT03840811COMPLETEDPHASE1
View Study
27 participants
INTERVENTIONAL
Chapel Hill, United States
Started: Apr 23, 2017

Comparison of Efficacy of Two Combination Regimens for the Neisseria Gonorrhoeae and Chlamydia Coinfection

NCT05216744COMPLETEDPHASE2
View Study
125 participants
INTERVENTIONAL
Haiphong, Vietnam
Started: Jul 15, 2021

Effectiveness of HIV/Sexually Transmitted Infection Training for Physicians in China

NCT00644150COMPLETEDNA
View Study
1.37K participants
INTERVENTIONAL
Hefei, China
Started: Apr 1, 2007